Literature DB >> 5557677

The use of prostaglandin E 2 in the management of intrauterine death, missed abortion and hydatidiform mole.

G M Filshie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5557677     DOI： 10.1111/j.1471-0528.1971.tb00194.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Br Commonw        ISSN： 0022-3204


× No keyword cloud information.
  5 in total

1.  Extra-amniotic prostaglandin induction of labour supplemented with intravenous oxytocin following fetal death in utero.

Authors:  S Kehoe; M J Mylotte
Journal:  Ir J Med Sci       Date:  1990 Sep-Dec       Impact factor: 1.568

Review 2.  Clinical use of prostaglandins in obstetrics.

Authors:  A Gillespie
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 3.  Prostaglandins: pharmacology and clinical application.

Authors:  S M Karim; K Hillier
Journal:  Drugs       Date:  1974       Impact factor: 9.546

4.  [Combination of prostaglandine F 2 and paracervical block in the missed abortion and intrauterine fetal death].

Authors:  E J Hickl; H Mickan; D Walther
Journal:  Klin Wochenschr       Date:  1973-02-01

5.  Intracervical instillation of PGE2-gel in patients with missed abortion or intrauterine fetal death.

Authors:  G Ekman; N Uldbjerg; L Wingerup; U Ulmsten
Journal:  Arch Gynecol       Date:  1983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.